REMODELING OF THE RIGHT HEART AND THE LEVEL OF BRAIN NATRIURETIC PEPTIDE IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION: A COMPARATIVE CROSS-SECTIONAL OBSERVATIONAL STUDY

Aim. To study the right heart remodeling and level of N-terminal brain natriuretic peptide (Nt-proBNP) in patients with chronic thromboembolic pulmonary hypertension (CTEPH). Material and methods. Patients (n=79) after pulmonary embolism were included into the study. The main group consisted of pati...

Full description

Bibliographic Details
Main Authors: A. A. Klimenko, N. A. Shostak, N. A. Demidova, I. V. Novikov, S. M. Sorokoletov, S. V. Madoyan
Format: Article
Language:English
Published: Столичная издательская компания 2015-09-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
Online Access:http://www.rpcardio.ru/jour/article/view/2
_version_ 1827848789649522688
author A. A. Klimenko
N. A. Shostak
N. A. Demidova
I. V. Novikov
S. M. Sorokoletov
S. V. Madoyan
author_facet A. A. Klimenko
N. A. Shostak
N. A. Demidova
I. V. Novikov
S. M. Sorokoletov
S. V. Madoyan
author_sort A. A. Klimenko
collection DOAJ
description Aim. To study the right heart remodeling and level of N-terminal brain natriuretic peptide (Nt-proBNP) in patients with chronic thromboembolic pulmonary hypertension (CTEPH). Material and methods. Patients (n=79) after pulmonary embolism were included into the study. The main group consisted of patients (n=43) with an increase in systolic pulmonary artery pressure (SPAP) >30 mm Hg: 30 (37.9%)  patients had pulmonary hypertension (PH) degree I, and 13 (16.5%)  — PH degree II–III. Group of comparison con- sisted of 36 patients expired pulmonary embolism and having SPAP <30 mm Hg. The control group consisted of 20 people. 6-minute walk test (6-MWT) and Doppler echocardiography were performed in all patients. Besides myocardial tissue Doppler echocardiography and assessment of Nt-proBNP level were performed in 38 and 71 patients, respectively. Results. Dyspnea occurred in 90.7% of patients with various degrees of PH and 80.5% of patients with normal SPAP. Patients without PH and with PH I complained of palpitations, weakness, fatigue, and dizziness with similar frequency. Patients with PH I were comparable with ones of comparison group in 6-MWT distance that dramatically decreased in patients with PH II–III. Enlargement of the right atrium (RA) and/or right ventricular (RV) was observed in 76.7% of patients with PH I and 100% of patients with PH II–III. RV diastolic function abnormalities (E/A<1 and E/A>2) were detected in 19.4%, 16.7% and 61.5% of patients of comparison group, PH I and PH II–III patients, respectively. According to myocardial tissue Doppler echocardiography Em/Am<1 was observed in 8 (72.7%) patients of the comparison group and in 13 (76.4%) patients with PH. Nt-proB-NP level was 17.3 [2.3, 33.9] fmol/ml in PH I patients and 142.1 [62.1, 171.8] fmol/ml in PH II–III patients. Nt-proBNP level was 6.5 [3.1, 18.3] fmol/mL in patients of the comparison group, and it was higher than this in patients of the control group (3.5 [1.8, 7.5 fmol/ml]. Conclusion. Various indicators of heart remodeling and RV diastolic dysfunction were found in the majority of patients after pulmonary embolism, including those with nor- mal SPAP. Elevation of Nt-proBNP level adequately reflects the severity of RV dysfunction in CTEPH patients only in PH II–III. This marker has low diagnostic value in patients with- out CTEPH and PH I patients.
first_indexed 2024-03-12T09:53:03Z
format Article
id doaj.art-233d9e143981474683526d40fd0435fc
institution Directory Open Access Journal
issn 1819-6446
2225-3653
language English
last_indexed 2024-03-12T09:53:03Z
publishDate 2015-09-01
publisher Столичная издательская компания
record_format Article
series Рациональная фармакотерапия в кардиологии
spelling doaj.art-233d9e143981474683526d40fd0435fc2023-09-02T12:21:04ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532015-09-019325826410.1234/1819-6446-2013-3-258-2642REMODELING OF THE RIGHT HEART AND THE LEVEL OF BRAIN NATRIURETIC PEPTIDE IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION: A COMPARATIVE CROSS-SECTIONAL OBSERVATIONAL STUDYA. A. Klimenko0N. A. Shostak1N. A. Demidova2I. V. Novikov3S. M. Sorokoletov4S. V. Madoyan5Российский национальный исследовательский медицинский университет имени Н.И. Пирогова, МоскваРоссийский национальный исследовательский медицинский университет имени Н.И. Пирогова, МоскваРоссийский национальный исследовательский медицинский университет имени Н.И. Пирогова, МоскваРоссийский национальный исследовательский медицинский университет имени Н.И. Пирогова, МоскваРоссийский национальный исследовательский медицинский университет имени Н.И. Пирогова, Москва; Городская клиническая больница №1 имени Н.И. Пирогова, МоскваГородская клиническая больница №13, МоскваAim. To study the right heart remodeling and level of N-terminal brain natriuretic peptide (Nt-proBNP) in patients with chronic thromboembolic pulmonary hypertension (CTEPH). Material and methods. Patients (n=79) after pulmonary embolism were included into the study. The main group consisted of patients (n=43) with an increase in systolic pulmonary artery pressure (SPAP) >30 mm Hg: 30 (37.9%)  patients had pulmonary hypertension (PH) degree I, and 13 (16.5%)  — PH degree II–III. Group of comparison con- sisted of 36 patients expired pulmonary embolism and having SPAP <30 mm Hg. The control group consisted of 20 people. 6-minute walk test (6-MWT) and Doppler echocardiography were performed in all patients. Besides myocardial tissue Doppler echocardiography and assessment of Nt-proBNP level were performed in 38 and 71 patients, respectively. Results. Dyspnea occurred in 90.7% of patients with various degrees of PH and 80.5% of patients with normal SPAP. Patients without PH and with PH I complained of palpitations, weakness, fatigue, and dizziness with similar frequency. Patients with PH I were comparable with ones of comparison group in 6-MWT distance that dramatically decreased in patients with PH II–III. Enlargement of the right atrium (RA) and/or right ventricular (RV) was observed in 76.7% of patients with PH I and 100% of patients with PH II–III. RV diastolic function abnormalities (E/A<1 and E/A>2) were detected in 19.4%, 16.7% and 61.5% of patients of comparison group, PH I and PH II–III patients, respectively. According to myocardial tissue Doppler echocardiography Em/Am<1 was observed in 8 (72.7%) patients of the comparison group and in 13 (76.4%) patients with PH. Nt-proB-NP level was 17.3 [2.3, 33.9] fmol/ml in PH I patients and 142.1 [62.1, 171.8] fmol/ml in PH II–III patients. Nt-proBNP level was 6.5 [3.1, 18.3] fmol/mL in patients of the comparison group, and it was higher than this in patients of the control group (3.5 [1.8, 7.5 fmol/ml]. Conclusion. Various indicators of heart remodeling and RV diastolic dysfunction were found in the majority of patients after pulmonary embolism, including those with nor- mal SPAP. Elevation of Nt-proBNP level adequately reflects the severity of RV dysfunction in CTEPH patients only in PH II–III. This marker has low diagnostic value in patients with- out CTEPH and PH I patients.http://www.rpcardio.ru/jour/article/view/2легочная гипертензияхроническая тромбоэмболическая легочная гипертензиятромбоэмболия легочной артерииправый желудочекдиастолическая дисфункциятканевая миокардиальная допплерэхокардиографияN-концевой мозговой натрийуретический пептид
spellingShingle A. A. Klimenko
N. A. Shostak
N. A. Demidova
I. V. Novikov
S. M. Sorokoletov
S. V. Madoyan
REMODELING OF THE RIGHT HEART AND THE LEVEL OF BRAIN NATRIURETIC PEPTIDE IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION: A COMPARATIVE CROSS-SECTIONAL OBSERVATIONAL STUDY
Рациональная фармакотерапия в кардиологии
легочная гипертензия
хроническая тромбоэмболическая легочная гипертензия
тромбоэмболия легочной артерии
правый желудочек
диастолическая дисфункция
тканевая миокардиальная допплерэхокардиография
N-концевой мозговой натрийуретический пептид
title REMODELING OF THE RIGHT HEART AND THE LEVEL OF BRAIN NATRIURETIC PEPTIDE IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION: A COMPARATIVE CROSS-SECTIONAL OBSERVATIONAL STUDY
title_full REMODELING OF THE RIGHT HEART AND THE LEVEL OF BRAIN NATRIURETIC PEPTIDE IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION: A COMPARATIVE CROSS-SECTIONAL OBSERVATIONAL STUDY
title_fullStr REMODELING OF THE RIGHT HEART AND THE LEVEL OF BRAIN NATRIURETIC PEPTIDE IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION: A COMPARATIVE CROSS-SECTIONAL OBSERVATIONAL STUDY
title_full_unstemmed REMODELING OF THE RIGHT HEART AND THE LEVEL OF BRAIN NATRIURETIC PEPTIDE IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION: A COMPARATIVE CROSS-SECTIONAL OBSERVATIONAL STUDY
title_short REMODELING OF THE RIGHT HEART AND THE LEVEL OF BRAIN NATRIURETIC PEPTIDE IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION: A COMPARATIVE CROSS-SECTIONAL OBSERVATIONAL STUDY
title_sort remodeling of the right heart and the level of brain natriuretic peptide in patients with chronic thromboembolic pulmonary hypertension a comparative cross sectional observational study
topic легочная гипертензия
хроническая тромбоэмболическая легочная гипертензия
тромбоэмболия легочной артерии
правый желудочек
диастолическая дисфункция
тканевая миокардиальная допплерэхокардиография
N-концевой мозговой натрийуретический пептид
url http://www.rpcardio.ru/jour/article/view/2
work_keys_str_mv AT aaklimenko remodelingoftherightheartandthelevelofbrainnatriureticpeptideinpatientswithchronicthromboembolicpulmonaryhypertensionacomparativecrosssectionalobservationalstudy
AT nashostak remodelingoftherightheartandthelevelofbrainnatriureticpeptideinpatientswithchronicthromboembolicpulmonaryhypertensionacomparativecrosssectionalobservationalstudy
AT nademidova remodelingoftherightheartandthelevelofbrainnatriureticpeptideinpatientswithchronicthromboembolicpulmonaryhypertensionacomparativecrosssectionalobservationalstudy
AT ivnovikov remodelingoftherightheartandthelevelofbrainnatriureticpeptideinpatientswithchronicthromboembolicpulmonaryhypertensionacomparativecrosssectionalobservationalstudy
AT smsorokoletov remodelingoftherightheartandthelevelofbrainnatriureticpeptideinpatientswithchronicthromboembolicpulmonaryhypertensionacomparativecrosssectionalobservationalstudy
AT svmadoyan remodelingoftherightheartandthelevelofbrainnatriureticpeptideinpatientswithchronicthromboembolicpulmonaryhypertensionacomparativecrosssectionalobservationalstudy